Section Arrow
Quote
CLGN.NASDAQ
- CollPlant Biotechnologies Ltd
Quotes are at least 15-min delayed:2025/01/12 03:59 EST
Last
 4.1983
-0.1692 (-3.87%)
Day High 
4.51 
Prev. Close
4.3675 
1-M High
4.56 
Volume 
16.15K 
Bid
4
Ask
4.19
Day Low
4.1983 
Open
4.43 
1-M Low
3.24 
Market Cap 
50.03M 
Currency USD 
P/E -- 
%Yield 5.46 
10-SMA 3.92 
20-SMA 3.8 
50-SMA 3.96 
52-W High 6.75 
52-W Low 3.24 
Exchange NASDAQ 
Valuation Estimation
EPS (Current/Estimated)
-1.53/0.33
Enterprise Value
52.56M
Balance Sheet
Book Value Per Share
1.48
Cash Flow
Cash Flow Yield
--
Income Statement
Total Revenue
10.96M
Operating Revenue Per Share
1.75
Industry Comparison
More
Code Name   Last Change Change (%) P/E P/E Range
CDTConduit Pharmaceuticals0.1233+0.0413+50.37%-- 
MRSNMersana Therapeutics0.72-0.58-44.62%-- 
TNXPTonix Pharmaceuticals Holding Corp.0.2787+0.0227+8.87%-- 
ZVSAZyVersa Therapeutics1.47+0.29+24.58%0PE
SANASana Biotechnology3.66-0.64-14.88%-- 
Quotes are at least 15-min delayed：2025/01/12 03:59 EST
Industry overview quotes are at least 15 minutes delayed
Business Description
CollPlant Biotechnologies Ltd is a regenerative and aesthetic medicine company focused on 3D bioprinting of tissues and organs and medical aesthetics. Its products are based on its rhCollagen (recombinant human collagen) produced with CollPlant's proprietary plant based genetic engineering technology. These products address indications for the diverse fields of tissue repair, aesthetics, and organ manufacturing. The revenues include income from business collaborators and sales of the BioInk product for the development of 3D bioprinting of organs and tissues, sales of rhCollagen for the medical aesthetics market, and sales in Europe of the products for tendinopathy and wound healing. The company operates in United States, which derives key revenue, Canada, Europe and Other, and Israel.
Information provided by: etnet
Terms and Conditions
Bank of China (Hong Kong) Limited
Disclaimer:
This information is provided by ET Net Limited ("ET Net") and/or its third party information providers (the "Sources") and is strictly for reference only. It is not intended to provide any financial or professional advice and any person should not rely upon the same as such. You should obtain relevant and specific professional advice before making any investment decision. Before making an investment decision, you should consider, with the assistance of your professional securities adviser, whether the information is appropriate in light of your particular investment needs, objectives and financial circumstances. ET Net and the Sources endeavor to ensure the accuracy and reliability of the information provided. Notwithstanding the aforesaid, ET Net, the Sources and Bank of China (Hong Kong) Limited do not guarantee or make any representation, warranty or undertaking as to the accuracy, reliability, completeness or timeliness of this information, and accept no responsibility or liability whatsoever (whether in tort or contract or otherwise) for any loss or damage howsoever arising from or in reliance upon the whole or any part of such information.